How much is Toxic Scorpion worth right now?

Toxic Scorpion from Innistrad: Double Feature is trading around $0.22 on the secondary market. TCGIndex refreshes this price every day.

Is Toxic Scorpion going up or down?

Toxic Scorpion is up +19.6% over 30 days, down -11.6% over 7 days. The full price history is on this page.

Is Toxic Scorpion a good investment?

TCGIndex doesn't give financial advice, but here's the data worth knowing: it sits around $0.22, up +19.6% over the last 30 days, with high volatility. Prices can move fast, so look at the trend and your own timeframe before you buy.

Toxic Scorpion

Innistrad: Double FeatureCommon#491

Investment snapshot●Neutral50%

$0.91

Trend

Neutral

Momentum

Cooling

Volatility

High

30-day

+19.6%

Why this card is worth watching

Up 20% over the last month
Prices are swinging — size entries with care

View listings on TCGplayer

eBay sold prices

Price History27 days

$0.91

7d Changei

-11.59%

30d Changei

+19.61%

Volatilityi

high

Trendi

— neutral

30d Rangei

$0.61$1.14

Variants (6)

Condition	Printing	Price	7d Avg	30d Avg	Trend
Near Mint	Foil	$0.91	$0.93	$0.81	▲	Live
Near Mint	Normal	$0.31	$0.31	$0.32	—	Live
Lightly Played	Normal	$0.22	$0.21	$0.21	—	Live
Lightly Played	Foil	$0.53	$0.44	$0.42	▲	Live
Moderately Played	Normal	$0.50	$0.50	$0.50	—	Live
Moderately Played	Foil	$0.50	—	$0.50	—	Live

Toxic Scorpion FAQ

How much is Toxic Scorpion worth right now?: Toxic Scorpion from Innistrad: Double Feature is trading around $0.22 on the secondary market. TCGIndex refreshes this price every day.
Is Toxic Scorpion going up or down?: Toxic Scorpion is up +19.6% over 30 days, down -11.6% over 7 days. The full price history is on this page.
Is Toxic Scorpion a good investment?: TCGIndex doesn't give financial advice, but here's the data worth knowing: it sits around $0.22, up +19.6% over the last 30 days, with high volatility. Prices can move fast, so look at the trend and your own timeframe before you buy.

Toxic Scorpion

Toxic Scorpion FAQ

More cards from Innistrad: Double Feature